220 related articles for article (PubMed ID: 9798081)
1. Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease.
Piggott MA; Perry EK; Marshall EF; McKeith IG; Johnson M; Melrose HL; Court JA; Lloyd S; Fairbairn A; Brown A; Thompson P; Perry RH
Biol Psychiatry; 1998 Oct; 44(8):765-74. PubMed ID: 9798081
[TBL] [Abstract][Full Text] [Related]
2. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
[TBL] [Abstract][Full Text] [Related]
3. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
Court JA; Piggott MA; Lloyd S; Cookson N; Ballard CG; McKeith IG; Perry RH; Perry EK
Neuroscience; 2000; 98(1):79-87. PubMed ID: 10858614
[TBL] [Abstract][Full Text] [Related]
4. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
Piggott MA; Ballard CG; Dickinson HO; McKeith IG; Perry RH; Perry EK
Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
[TBL] [Abstract][Full Text] [Related]
5. Regulation of dopamine D₃ receptor in the striatal regions and substantia nigra in diffuse Lewy body disease.
Sun J; Cairns NJ; Perlmutter JS; Mach RH; Xu J
Neuroscience; 2013 Sep; 248():112-26. PubMed ID: 23732230
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.
Piggott MA; Owens J; O'Brien J; Colloby S; Fenwick J; Wyper D; Jaros E; Johnson M; Perry RH; Perry EK
J Chem Neuroanat; 2003 Mar; 25(3):161-73. PubMed ID: 12706204
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants.
Cyr M; Morissette M; Barden N; Beaulieu S; Rochford J; Di Paolo T
Neuroscience; 2001; 102(1):151-8. PubMed ID: 11226678
[TBL] [Abstract][Full Text] [Related]
8. Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol.
Chinaglia G; Alvarez FJ; Probst A; Palacios JM
Neuroscience; 1992 Jul; 49(2):317-27. PubMed ID: 1436470
[TBL] [Abstract][Full Text] [Related]
9. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
10. [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
Bokobza B; Ruberg M; Scatton B; Javoy-Agid F; Agid Y
Eur J Pharmacol; 1984 Mar; 99(2-3):167-75. PubMed ID: 6734727
[TBL] [Abstract][Full Text] [Related]
11. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
12. Gamma-aminobutyric acidA and benzodiazepine receptor alterations in the rat brain after unilateral 6-hydroxydopamine lesions of the medial forebrain bundle.
Araki T; Matsubara M; Fujihara K; Kato H; Imai Y; Itoyama Y
Neurol Res; 2002 Jan; 24(1):107-12. PubMed ID: 11783749
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.
Przedborski S; Levivier M; Jiang H; Ferreira M; Jackson-Lewis V; Donaldson D; Togasaki DM
Neuroscience; 1995 Aug; 67(3):631-47. PubMed ID: 7675192
[TBL] [Abstract][Full Text] [Related]
14. Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers.
Beach TG; Walker DG; Sue LI; Newell A; Adler CC; Joyce JN
J Neuropathol Exp Neurol; 2004 Apr; 63(4):329-37. PubMed ID: 15099023
[TBL] [Abstract][Full Text] [Related]
15. Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts.
Kraemmer J; Kovacs GG; Perju-Dumbrava L; Pirker S; Traub-Weidinger T; Pirker W
Mov Disord; 2014 Dec; 29(14):1767-73. PubMed ID: 25048738
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptics and dopamine transporters.
Reader TA; Ase AR; Huang N; Hébert C; van Gelder NM
Neurochem Res; 1998 Jan; 23(1):73-80. PubMed ID: 9482270
[TBL] [Abstract][Full Text] [Related]
17. CNS compensation to dopamine neuron loss in Parkinson's disease.
Lloyd KG
Adv Exp Med Biol; 1977; 90():255-66. PubMed ID: 930746
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus.
Bohr IJ; Ray MA; McIntosh JM; Chalon S; Guilloteau D; McKeith IG; Perry RH; Clementi F; Perry EK; Court JA; Piggott MA
Exp Neurol; 2005 Feb; 191(2):292-300. PubMed ID: 15649484
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
Newman-Tancredi A; Cussac D; Brocco M; Rivet JM; Chaput C; Touzard M; Pasteau V; Millan MJ
Brain Res; 2001 Nov; 920(1-2):41-54. PubMed ID: 11716810
[TBL] [Abstract][Full Text] [Related]
20. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN
Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
